EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea

Artem Chayka, Matěj Danda, Alžběta Dostálková, Vojtěch Spiwok, Lamija Zijadic, Anna Klimešová, Marina Kapisheva, Michala Zgarbová, Jan Weber, Tomáš Ruml, Michaela Rumlová iD, Zlatko Janeba iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500644 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Artem Chayka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 6, 160 00, Czech Republic. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, RNA-Dependent RNA Polymerase, Enzyme Inhibitors. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Czech Science Foundation, Institute of Organic Chemistry and Biochemistry, National Institute of virology and bacteriology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic, caused by the highly transmissible SARS‐CoV‐2 virus, has highlighted the urgent need for effective small‐molecule antivirals. To date, only a few such agents, including molnupiravir and remdesivir, have been approved by the FDA. In our previous study, a novel class of SARS‐CoV‐2 RNA‐dependent RNA polymerase (RdRp) inhibitors based on an N , N ′‐diphenylurea scaffold was identified; however, these compounds exhibited poor aqueous solubility and significant cytotoxicity. Herein, the design, synthesis, and evaluation of twenty‐seven new derivatives aimed at improving solubility and reducing cytotoxicity through targeted scaffold modifications are reported. Seven analogs display enhanced aqueous solubility (kinetic solubility > 10 µM), and nine compounds show residual RdRp activity (RA—determined at 10 μM concentration of screened compounds) below 50%, with the most potent analog achieving an RA value of 34%. Despite these improvements, cytotoxicity remains a limitation across the series. These findings provide valuable structure–activity relationship insights and direct ongoing optimization efforts toward developing less toxic, soluble RdRp inhibitors with improved antiviral profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsRNA-Dependent RNA PolymeraseEnzyme InhibitorsCoronavirus RNA-Dependent RNA PolymeraseUreaPhenylurea CompoundsHumansStructure-Activity RelationshipAllosteric RegulationCOVID-19 Drug TreatmentMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

SARS‐CoV‐2RdRpallosteric inhibitorkinetic solubility

Substanzen

Antiviral AgentsRNA-Dependent RNA PolymeraseEnzyme InhibitorsCoronavirus RNA-Dependent RNA PolymeraseUreaPhenylurea Compounds

Autor:innen und Institutionen

  • Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 6, 160 00, Czech Republic.
  • Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, Prague 6, 166 28, Czech Republic.
  • Department of Biochemistry and Microbiology, University of Chemistry and Technology, Prague, Technická 5, Prague 6, 166 28, Czech Republic.
  • Department of Genetics and Microbiology, Faculty of Sciences, Charles University, Viničná 5, Prague 2, 128 44, Czech Republic.

ORCID-Profile: Michaela Rumlová, Zlatko Janeba

Förderung

  • Czech Science Foundation
  • Institute of Organic Chemistry and Biochemistry
  • National Institute of virology and bacteriology

Zitieren

APA

Chayka, A., Danda, M., Dostálková, A., Spiwok, V., Zijadic, L., Klimešová, A., Kapisheva, M., Zgarbová, M., Weber, J., Ruml, T., Rumlová, M., & Janeba, Z. (2026). Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea. ChemMedChem. https://doi.org/10.1002/cmdc.202500644

Vancouver

Chayka A, Danda M, Dostálková A, Spiwok V, Zijadic L, Klimešová A, et al. Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea. ChemMedChem. 2026. doi:10.1002/cmdc.202500644

BibTeX
@article{Chayka2026,
  author = {Chayka, Artem and Danda, Matěj and Dostálková, Alžběta and Spiwok, Vojtěch and Zijadic, Lamija and Klimešová, Anna and Kapisheva, Marina and Zgarbová, Michala and Weber, Jan and Ruml, Tomáš and Rumlová, Michaela and Janeba, Zlatko},
  title = {Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase Based on N , N′ ‐Diphenylurea},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500644}
}
Kostenlos starten →